Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Chine

 
Quantité totale PI 818
Rang # Quantité totale PI 1 609
Note d'activité PI 3,4/5.0    531
Rang # Activité PI 1 356

Brevets

Marques

151 0
65 0
602 0
0
 
Dernier brevet 2025 - Salt of substituted amino six-me...
Premier brevet 1995 - Huperzine a derivatives, their p...

Derniers inventions, produits et services

2024 Invention Use of chemokine receptor 2 antagonist in preparation of treatment of anxiety disorders associate...
Invention Purine compound and use thereof. Provided are a purine compound and the use thereof. The purine c...
Invention Pyrazolotriazine and pyrazolopyrimidine derivatives, preparation method therefor, pharmaceutical ...
Invention Endoglycosidase s2 mutant, preparation method therefor and use thereof in antibody glycosylation ...
Invention Disaccharide-acylhydrazone or disaccharide-hydrazide linker, glyco-engineered antibody and sugar-...
Invention Pharmaceutical composition containing heteroaryl oxynaphthalene compound, preparation method ther...
Invention Heterocyclic-substituted indazolone compounds, preparation method therefor, pharmaceutical compos...
Invention Indazolone compound, preparation method therefor, pharmaceutical composition, and use. Disclosed ...
Invention Cyclic 2-aminopyrimidine compound and pharmaceutical composition and use thereof. Provided are a ...
Invention Preparation and use of fluorescent probe targeting gpr84 receptor. Disclosed in the present inven...
Invention Preparation method for spirocyclic tetrahydro-γ-carboline derivative, and use of spirocyclic tetr...
Invention N2-3-fluoro-5-substituted phenyl-2-aminopyrimidine derivative, preparation method therefor and ph...
Invention Irak4 degrader and pharmaceutical composition and pharmaceutical use thereof. The present inventi...
Invention Azetidine compound and medical use thereof. The present invention relates to an azetidine compoun...
Invention Fap-targeting compound, and radionuclide-labeled complex based thereon, and preparation method th...
Invention Protein degradation agent, and pharmaceutical composition and use thereof. A protein degradation ...
Invention Gastrodiae rhizoma oligosaccharide compound, and preparation method therefor and use thereof. The...
Invention Fap inhibitor, fap-targeted nuclide probe. and application thereof. The present invention relates...
Invention Macrocyclic chelating agent capable of site-specific modification, radionuclide probe, and use th...
Invention Conserved druggable pocket for class b gpcrs and use thereof. Provided are a conserved druggable ...
Invention Nav1.8 inhibitors, preparation method therefor and use thereof. Provided in the present invention...
Invention Use of combination of lsd1 inhibitor and drug to treat cancer. A use of a combination of an LSD1 ...
Invention Pharmaceutical composition for oral mucosal delivery, pharmaceutical preparation thereof and use ...
Invention Pyridazinone trpc4/5 inhibitor and use thereof. Disclosed in the present invention is a pyridazin...
Invention Ror1-targeting antibody, antibody-drug conjugate comprising same, preparation method therefor, an...
Invention Her2 targeted peptide and use thereof. Provided are a HER2 targeted peptide and the use thereof. ...
Invention Double site-directed antibody-functional molecular conjugate, and preparation method therefor and...
Invention Phosphodiesterase-4 inhibitor, pharmaceutical composition comprising same, and use thereof. The p...
Invention Use of naphthylamide compound in treatment of meningioma. The present invention provides a use of...
Invention Use of lys01 or salt thereof in preparation of kir4.1 potassium channel inhibitor. The present in...
2023 Invention Preparation of a class of lysine-specific demethylase 1 (lsd1) inhibitors. The present invention...
Invention .alpha., .beta.-unsaturated amide compound, and preparation method therefor, and pharmaceutical c...
Invention Isoquinolinone compound, and preparation method and use therefor. Provided are an isoquinolinone...
Invention Salt of substituted amino six-membered nitric heterocyclic compound, crystal form thereof, method...
Invention Epa-ee lipid nanocomposite, formulation thereof, preparation method therefor, and application the...
Invention Cyclic(alkyl)(amino)alkoxy-substituted aryl-pyrone compound and use thereof. A novel compound re...
Invention High-selectivity kcnq4 potassium channel agonist, preparation method therefor and use thereof. D...
Invention Steroid compound, and preparation method therefor and use thereof. Disclosed in the present inve...
2022 Invention Somatostatin receptor subtype 5 antagonists, and pharmaceutical composition and use thereof. Pro...
Invention Aromatic heterocyclic compound and application thereof. Disclosed are an aromatic heterocyclic c...
Invention Cyano compound, and preparation method therefor and use thereof. The present invention provides ...
Invention Long-chain compound that acts on acly, preparation method therefor and use thereof. A long-chain...
Invention Sulfonylurea compound, preparation method therefor, and application thereof. The present inventi...
Invention Urea compound containing 2-heteroaromatic ring substitution, preparation method therefor and use ...
Invention Isoquinoline alkaloid compound, and preparation method therefor and use thereof. Provided in the...
Invention Application of novel coronavirus vaccine peptide and nanoemulsion preparation thereof in preventi...
Invention Class of alkylphenol compounds and preparation method therefor. Provided are a class of alkylphe...
Invention Heterocyclic compound for inhibiting shp2 activity, preparation method therefor and use thereof. ...
Invention Lignan derivative, preparation method therefor and use thereof. Disclosed in the present inventi...
2021 Invention Isoquinoline compound, manufacturing method therefor, and application thereof. Provided are an i...